FDA Approves First TAVR Therapy for Asymptomatic Severe Aortic Stenosis Patients
Edwards Lifesciences' SAPIEN 3 platform has received FDA approval for treating asymptomatic patients with severe aortic stenosis, marking the first such approval for transcatheter aortic valve replacement in this patient population.
© Copyright 2025. All Rights Reserved by MedPath